Greenline Partners, LLC Abb Vie Inc. Transaction History

Greenline Partners, LLC

$624 Million
Q1 2024

A detailed history of Greenline Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Greenline Partners, LLC holds 1,955 shares of ABBV stock, worth $324,451. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,955

Previous 1,955 -0.0%

Holding current value

$324,451

Previous $302,000 17.88%

% of portfolio

0.06%

Previous 0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $6,880 - $7,748	50 Added 2.62%	1,955 $302,000
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $22,406 - $26,870	162 Added 9.29%	1,905 $308,000
Q4 2021 Feb 15, 2022	BUY	$107.43 - $135.93 $187,250 - $236,925	1,743 New	1,743 $236,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $988,807 - $1.32 Million	-13,477 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $809,217 - $1.23 Million	-12,546 Reduced 48.21%	13,477 $1.03 Million

Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $637,629 - $797,810	-8,840 Reduced 25.36%	26,023 $2.3 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $196,182 - $235,867	3,115 Added 9.81%	34,863 $2.64 Million
Q2 2019 Aug 05, 2019	SELL	$65.7 - $83.98 $208,137 - $266,048	-3,168 Reduced 9.07%	31,748 $2.31 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $469,705 - $552,820	-6,089 Reduced 14.85%	34,916 $2.81 Million
Q3 2018 Oct 15, 2018	BUY	$88.91 - $98.84 $110,692 - $123,055	1,245 Added 3.13%	41,005 $3.87 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $1.43 Million - $1.69 Million	15,916 Added 66.75%	39,760 $3.68 Million
Q1 2018 Jun 21, 2018	BUY	$92.01 - $123.21 $1.4 Million - $1.88 Million	15,244 Added 177.26%	23,844 $2.26 Million
Q4 2017 Jun 21, 2018	BUY	$89.56 - $98.21 $770,216 - $844,606	8,600	8,600 $832,000

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenline Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenline Partners, LLC with notifications on news.

Account

Greenline Partners, LLC Abb Vie Inc. Transaction History